Moneycontrol PRO
UPCOMING EVENT:Know how Global Investing can be spread beyond the US markets by joining an engaging webinar on November 30, 11:30 a.m.
you are here: HomeNewsBusiness

Sun Pharmaceutical Industries Q2 PAT seen up 15.6% YoY to Rs 2,094.8 cr: Prabhudas Lilladher

Net Sales are expected to increase by 13.3 percent Y-o-Y (down 0.9 percent Q-o-Q) to Rs 9,584.3 crore, according to Prabhudas Lilladher.

October 06, 2021 / 06:00 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its second quarter (July-September’ 21) earnings estimates for the Pharma sector. The brokerage house expects Sun Pharmaceutical Industries to report net profit at Rs 2,094.8 crore up 15.6% year-on-year (up 45.1% quarter-on-quarter).


Net Sales are expected to increase by 13.3 percent Y-o-Y (down 0.9 percent Q-o-Q) to Rs 9,584.3 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 27.4 percent Y-o-Y (down 3.5 percent Q-o-Q) to Rs 2,674 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark